Hepatitis B Vaccine 'Significantly Increased' IL-6, A io-Marker For Autism: MSM Silence

[donnay]

HEPATITIS B VACCINE ‘SIGNIFICANTLY INCREASED’ IL-6, A BIO-MARKER FOR AUTISM’: MAINSTREAM MEDIA SILENCE

WORLD MERCURY PROJECTMAY 18, 2018

BY WORLD MERCURY PROJECT BOARD MEMBER JB HANDLEY, CO-FOUNDER, GENERATION RESCUE
GUANDONG, China —Sun Yat-sen University’s (a Top 10 university in China) Dr. Zhibin Yao is not a household name in the American autism community, but perhaps he should be. Not only is he American-educated (University of Pittsburgh) and the author of 33 peer-reviewed studies, but he’s also the lead author of two of the most important biological studies ever done analyzing how, exactly, a vaccine can cause autism.

In 2015, Dr. Yao was the lead author of “Neonatal vaccination with bacillus Calmette–Guérin and hepatitis B vaccines modulates hippocampal synaptic plasticity in rats,” the first study that ever looked at the impact ANY vaccine might have on the brains of rats. I discussed this study in detail in an extensive article I wrote in April titled, “International scientists have found autism’s cause. What will Americans do?.” Vaccine Papers, a website dedicated to a rigorous, science-based analysis of the risks and benefits of vaccines, explained the paper this way:

“This is the first study to test the effects of immune activation by vaccination on brain development. All other studies of immune activation have used essentially pathological conditions that mimic infection and induce a strong fever. A criticism I have heard often from vaccine advocates is that the immune activation experiments are not relevant to vaccines because vaccines cause a milder immune activation than injections of poly-IC or lipopolysaccharide (two types of immune system activators). This new study demonstrates that vaccines can affect brain development via immune activation. Hence, the immune activation experiments are relevant to vaccines…The hep B vaccine increased IL-6 in the hippocampus (the only brain region analyzed for cytokines).”

Despite its importance, explaining Dr. Yao’s 2015 paper to the average person wasn’t easy, partly because his study covered a number of other topics, meaning you had to isolate the data that implicated the Hepatitis B vaccine, and then explain it. With his next paper, however, Dr. Yao and his team made explaining everything much easier, and left very little to interpretation.

The authors noted that the HBV [Hepatitis B vaccinated] mice showed ‘significantly increased’ IL-6, which we know is a biomarker for autism.
So much bigger than Wakefield, and zero media coverage

In 1998, Dr. Andrew Wakefield ended up crucified for a paper that only noted what some parents had reported–namely, that their children regressed into autism after the MMR vaccine. Dr. Yao’s second paper, on the other hand, conducted a thorough study of the Hepatitis B vaccine’s impact on the brains of mice, and did so versus a control group of mice who received a saline placebo. This is a “gold standard” animal study that you would typically do BEFORE a drug was introduced to the human population. In a world where vaccines were treated like other prescription drugs, Dr. Yao’s study would have sent up a giant red flag about the neurotoxicity of the Hepatitis B vaccine. Of course, that didn’t happen, and this is the first time you’ve probably ever heard of this study:

Read more: http://www.collective-evolution.com/...media-silence/

[Zippyjuan]

‘significantly increased’ IL-6, which we know is a biomarker for autism

Actually there is no identified biomarker for autism. IL-6 is a marker for stress- not autism.

https://www.sciencedirect.com/scienc...67488911000425


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655021/

Autism Spectrum Disorders (ASD) are a heterogeneous group of neurodevelopmental disorders. Recognized causes of ASD include genetic factors, metabolic diseases, toxic and environmental factors, and a combination of these. Available tests fail to recognize genetic abnormalities in about 70% of ASD children, where diagnosis is solely based on behavioral signs and symptoms, which are difficult to evaluate in very young children. Although it is advisable that specific psychotherapeutic and pedagogic interventions are initiated as early as possible, early diagnosis is hampered by the lack of nongenetic specific biological markers. In the past ten years, the scientific literature has reported dozens of neurophysiological and biochemical alterations in ASD children; however no real biomarker has emerged.

[NorthCarolinaLiberty]

Actually there is no identified biomarker for autism. IL-6 is a marker for stress- not autism.

https://www.sciencedirect.com/scienc...67488911000425


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655021/

Actually, the word "real" is an adjective, which often suggests interpretation.

Instead of you being paid to be contrary and rushing to post on RPF, maybe you should actually look into it. If you did that however, then you would actually be joining a discussion--something you claim to do, but don't actually want.

The literature I find says to me that this is an actual discussion among researchers. It's a developing area of research. I find many articles on this. Here are just five:

1. Synthesis and application of a "plastic antibody" in electrochemical microfluidic platform for oxytocin determination.
By: Sharma PS; Iskierko Z; Noworyta K; Cieplak M; Borowicz P; Lisowski W; D'Souza F; Kutner W, Biosensors & Bioelectronics [Biosens Bioelectron], ISSN: 1873-4235, 2018 Feb 15; Vol. 100, pp. 251-258

Excerpt: By means of molecular imprinting of a conducting polymer, molecular cavities selective for oxytocin nonapeptide, an autism biomarker, were designed.


.
2. Brain responses to biological motion predict treatment outcome in young adults with autism receiving Virtual Reality Social Cognition Training: Preliminary findings.
By: Yang YJD; Allen T; Abdullahi SM; Pelphrey KA; Volkmar FR; Chapman SB, Behaviour Research And Therapy [Behav Res Ther], ISSN: 1873-622X, 2017 Jun; Vol. 93, pp. 55-66

Excerpt: To our knowledge, this is the first pilot study that shows neuroimaging-based predictive biomarkers for treatment effectiveness in adults with ASD.



3. Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder.
By: Singh S; Yazdani U; Gadad B; Zaman S; Hynan LS; Roatch N; Schutte C; Marti CN; Hewitson L; German DC, Journal Of Neuroinflammation [J Neuroinflammation], ISSN: 1742-2094, 2017 Jun 02; Vol. 14 (1), pp. 113

Excerpt: Conclusions: These data suggest that a panel of proteins may be useful as a putative blood biomarker for ASD.



4. Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis.
By: Gabriele S; Sacco R; Persico AM, European Neuropsychopharmacology: The Journal Of The European College Of Neuropsychopharmacology [Eur Neuropsychopharmacol], ISSN: 1873-7862, 2014 Jun; Vol. 24 (6), pp. 919-29

Excerpt: In summary, despite some limitations mainly due to small study sample sizes, our results significantly reinforce the reliability of elevated 5-HT blood levels as a biomarker in ASD, providing practical indications potentially useful for its inclusion in multi-marker diagnostic panels for clinical use.



5. Plasma anandamide concentrations are lower in children with autism spectrum disorder.
By: Karhson DS; Krasinska KM; Dallaire JA; Libove RA; Phillips JM; Chien AS; Garner JP; Hardan AY; Parker KJ, Molecular Autism [Mol Autism], ISSN: 2040-2392, 2018 Mar 12; Vol. 9, pp. 18




Source: Medline